British Journal of Medical & Surgical Urology
Volume 3, Issue 1 , Pages 5-10 , January 2010

Predictors of successful trial without catheter in acute urinary retention

Received 15 March 2009 ,Revised 15 July 2009 ,Accepted 25 September 2009.

References 

  1. Armitage TC, Cooper EH, Newling DWW, Robinson MRG, Appleyard I. The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. Br J Urol. 1988;62:584–589
  2. Morote J, Ruibal A, Palou J. Evaluation of prostate specific antigen and prostatic acid phosphatase specificity. Study of false values. Int J Biol Markers. 1986;1:141–146
  3. Spiro LH, Labay G, Orkin LA. Prostatic infarction—role in acute urinary retention. Urology. 1974;3:345–347
  4. Erdogan K, Gurdal M, Tekin A, Kirecci S, Sengor F. The effect of urethral catheterisation on serum prostate-specific antigen levels in male patients with acute urinary retention. Yonsei Med J. 2003;44:676–678
  5. Ward JF, Bartsch G, Sebo TJ, Pinggera GM, Blute ML, Zincke H. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0–2ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?. Urol Oncol. 2004;22:40–47
  6. McNeill SA, Hargreave TB. Efficacy of PSA in the detection of carcinoma of the prostate in patients presenting with acute urinary retention. J R Coll Surg Edinb. 2000;45:227–230
  7. Gosselaar C, Kranse R, Roobol MJ, Roemeling S, Schroeder FH. The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer. Prostate. 2008;68:985–993

PII: S1875-9742(09)00160-8

doi: 10.1016/j.bjmsu.2009.09.028

British Journal of Medical & Surgical Urology
Volume 3, Issue 1 , Pages 5-10 , January 2010